Modern aspects of cutaneous neurogenic inflammation.
暂无分享,去创建一个
Sonja Ständer | Martin Schmelz | T. Luger | M. Steinhoff | S. Ständer | M. Schmelz | Martin Steinhoff | Thomas Luger | Stephan Seeliger | John C Ansel | J. Ansel | S. Seeliger
[1] N. Aiyar,et al. CGRP stimulates the adhesion of leukocytes to vascular endothelial cells , 1992, Peptides.
[2] C. Shaw,et al. Neuropeptides in psoriasis: an immunocytochemical and radioimmunoassay study. , 1991, The Journal of investigative dermatology.
[3] T. Luger,et al. Human dermal microvascular endothelial cells express the melanocortin receptor type 1 and produce increased levels of IL-8 upon stimulation with alpha-melanocyte-stimulating hormone. , 1997, Journal of immunology.
[4] T. Luger,et al. Mechanisms of the Antiinflammatory Effects of α‐MSH: Role of Transcription Factor NF‐κB and Adhesion Molecule Expression , 1999 .
[5] S. Grando. Biological functions of keratinocyte cholinergic receptors. , 1997, The journal of investigative dermatology. Symposium proceedings.
[6] U. McGovern,et al. Intracellular calcium as a second messenger following growth stimulation of human keratinocytes , 1995, The British journal of dermatology.
[7] Bull,et al. Expression of nerve growth factor receptors in cutaneous inflammation , 1998, The British journal of dermatology.
[8] D. Groneberg,et al. Simultaneous detection of receptor mRNA and ligand protein in human skin tissues , 2002, Journal of cutaneous pathology.
[9] A. Cupisti,et al. Endothelium-dependent and endothelium-independent skin vasoreactivity in the elderly , 2002, Aging clinical and experimental research.
[10] B. Iyengar. Modulation of melanocytic activity by acetylcholine. , 1989, Acta anatomica.
[11] P. Stjärne,et al. PACAP-induced plasma extravasation in rat skin , 1997, Regulatory Peptides.
[12] A. Blum,et al. Immunohistochemical localization of muscarinic acetylcholine receptors in primary and metastatic malignant melanomas , 1997, Journal of cutaneous pathology.
[13] E. G. Erdös,et al. Neutral endopeptidase in serum samples from patients with adult respiratory distress syndrome. Comparison with angiotensin-converting enzyme. , 1985, The American review of respiratory disease.
[14] W. Müller,et al. Muscarinic cholinergic receptors on intact human lymphocytes properties and subclass characterization , 1987, Biological Psychiatry.
[15] H. Tainio. Cytochemical localization of VIP‐stimulated adenylate cyclase activity in human sweat glands , 1987, The British journal of dermatology.
[16] A. Mauviel,et al. The Role of Proopiomelanocortin‐Derived Peptides in Skin Fibroblast and Mast Cell Functions , 1999, Annals of the New York Academy of Sciences.
[17] R. Funk,et al. Immunohistochemical detection of human skin nerve fibers. , 1997, Acta Histochemica.
[18] Yoshikatsu Suzuki,et al. Detection of Skin Over Cysts with Spina bifida May Be Useful Not Only for Preventing Neurological Damage during Labor but Also for Predicting Fetal Prognosis , 2000, Fetal Diagnosis and Therapy.
[19] A. Slominski,et al. Neuroendocrinology of the skin. , 2000, Endocrine reviews.
[20] V. Ferrans,et al. Influence of α‐melanocyte‐stimulating hormone and of ultraviolet radiation on the transfer of melanosomes to keratinocytes , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] K. Nordlind,et al. Inhibitory effect of vasoactive intestinal peptide on the challenge phase of allergic contact dermatitis in humans. , 1999, Acta dermato-venereologica.
[22] D. Pozo,et al. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies. , 1999, Journal of immunology.
[23] J. Olerud,et al. VCAM-1 expression on human dermal microvascular endothelial cells is directly and specifically up-regulated by substance P. , 1999, Journal of immunology.
[24] J. Levine,et al. Noradrenaline hyperalgesia is mediated through interaction with sympathetic postgahglionic neurone terminals rather than activation of primary afferent nociceptors , 1986, Nature.
[25] T. Williams,et al. Inflammatory oedema induced by synergism between calcitonin gene‐related peptide (CGRP) and mediators of increased vascular permeability , 1985, British journal of pharmacology.
[26] M. Delgado,et al. Pituitary Adenylate Cyclase-Activating Polypeptide Inhibits Collagen-Induced Arthritis: An Experimental Immunomodulatory Therapy1 , 2001, The Journal of Immunology.
[27] T. Luger. Neuromediators--a crucial component of the skin immune system. , 2002, Journal of dermatological science.
[28] K. H. Kim,et al. The neurosensory tachykinins substance P and neurokinin A directly induce keratinocyte nerve growth factor. , 2001, The Journal of investigative dermatology.
[29] A. Naukkarinen,et al. Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema , 2003, Archives of Dermatological Research.
[30] K. Pinkerton,et al. A Receptor-Mediated Mechanism of Nicotine Toxicity in Oral Keratinocytes , 2001, Laboratory Investigation.
[31] H. Shigematsu,et al. Parasympathetic innervation of cutaneous blood vessels by vasoactive intestinal polypeptide-immunoreactive and acetylcholinesterase-positive nerves: Histochemical and experimental study on rat lower lip , 1988, Neuroscience.
[32] M. Carr,et al. A Role for TRPV1 in Bradykinin-Induced Excitation of Vagal Airway Afferent Nerve Terminals , 2003, Journal of Pharmacology and Experimental Therapeutics.
[33] S. Shioda,et al. Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) and Its Receptors: Neuroendocrine and Endocrine Interaction , 1995, Frontiers in Neuroendocrinology.
[34] K. Nordlind,et al. Vasoactive Intestinal Polypeptide Inhibits the Established Allergic Contact Dermatitis in Humans a , 1996, Annals of the New York Academy of Sciences.
[35] L. Timmermann,et al. Involvement of neurokinins in antidromic vasodilatation in hairy and hairless skin of the rat hindlimb , 1999, Neuroscience.
[36] H. Vaudry,et al. PACAP Acts as a Neurotrophic Factor During Histogenesis of the Rat Cerebellar Cortex , 2000, Annals of the New York Academy of Sciences.
[37] B. Ulfhake,et al. Regulation of NGF‐family ligands and receptors in adulthood and senescence: correlation to degenerative and regenerative changes in cutaneous innervation , 2000, The European journal of neuroscience.
[38] M. Pittelkow,et al. Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo. , 1994, Biochimica et biophysica acta.
[39] T. Lundeberg,et al. Inhibitory effects of tachykinin receptor antagonists on thermally induced inflammatory reactions in a rat model. , 1999, Burns : journal of the International Society for Burn Injuries.
[40] S. Yamamoto,et al. Substance P induces tumor necrosis factor-alpha release from human skin via mitogen-activated protein kinase. , 2000, European journal of pharmacology.
[41] K. Paukkonen,et al. Immunohistochemical analysis of sensory nerves and neuropeptides, and their contacts with mast cells in developing and mature psoriatic lesions , 2004, Archives of Dermatological Research.
[42] D. Payan,et al. Interactions between neutral endopeptidase (EC 3.4.24.11) and the substance P (NK1) receptor expressed in mammalian cells. , 1994, The Biochemical journal.
[43] C. Kennedy,et al. The effects of topical doxepin on responses to histamine, substance P and prostaglandin E2 in human skin , 1997, The British journal of dermatology.
[44] L. Misery,et al. Skin, immunity and the nervous system , 1997, The British journal of dermatology.
[45] G. Mcgregor,et al. Expression and distribution of calcitonin receptor-like receptor in human hairy skin , 2002, Peptides.
[46] M. Hide,et al. Substance P- and antigen-induced release of leukotriene B4, prostaglandin D2 and histamine from guinea pig skin by different mechanisms in vitro , 1999, Archives of Dermatological Research.
[47] S. Brain,et al. Sensory neuropeptides: their role in inflammation and wound healing. , 1997, Immunopharmacology.
[48] S. Rose-John,et al. Role of interleukin‐6 and soluble IL‐6 receptor in region‐specific induction of astrocytic differentiation and neurotrophin expression , 1999 .
[49] I. Tatsuno,et al. Involvement of PACAP receptor in primary afferent fibre‐evoked responses of ventral roots in the neonatal rat spinal cord , 2001, British journal of pharmacology.
[50] S. Galli,et al. Stem cell factor influences neuro-immune interactions: The response of mast cells to pituitary adenylate cyclase activating polypeptide is altered by stem cell factor , 1999, Regulatory Peptides.
[51] J. Olerud,et al. Neutral endopeptidase expression and distribution in human skin and wounds. , 1999, The Journal of investigative dermatology.
[52] D. I. Våge,et al. The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. , 1996, Recent progress in hormone research.
[53] K. Bost,et al. Modulation of the mRNAs encoding substance P and its receptor in rat macrophages by LPS. , 1992, Regional immunology.
[54] T. Luger,et al. Modulation of Cutaneous Inflammation by Angiotensin-Converting Enzyme1 , 2003, The Journal of Immunology.
[55] G. Naumann,et al. [Immunity and the nervous system]. , 1962, Munchener medizinische Wochenschrift.
[56] G. D. Hunter,et al. Proteinase-Activated Receptors , 2001 .
[57] A. Slominski,et al. Human keratinocytes express functional α-MSH (MC1-R) receptors , 2001, In Vitro Cellular & Developmental Biology - Animal.
[58] U. Hipler,et al. Vasoactive intestinal peptide supports induced migration of human keratinocytes and their colonization of an artificial polyurethane matrix , 1997, Regulatory Peptides.
[59] J. Olerud,et al. Substance P induction of murine keratinocyte PAM 212 interleukin 1 production is mediated by the neurokinin 2 receptor (NK‐2R) , 2000, Experimental dermatology.
[60] M. Pittelkow,et al. Increased in vitro expression of beta2-adrenoceptors in differentiating lesional keratinocytes of vitiligo patients , 2004, Archives of Dermatological Research.
[61] T. Makino,et al. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis , 2002, The British journal of dermatology.
[62] N. Vergnolle. Proteinase-activated receptor-2-activating peptides induce leukocyte rolling, adhesion, and extravasation in vivo. , 1999, Journal of immunology.
[63] M. Reinecke,et al. Immunohistochemical localization of vasoactive intestinal polypeptide (VIP) in Merkel cells of various mammals: evidence for a neuromodulator function of the Merkel cell. , 1983, The Journal of investigative dermatology.
[64] M. Delgado,et al. VIP and PACAP Inhibit Activation Induced Apoptosis in T Lymphocytes , 2000, Annals of the New York Academy of Sciences.
[65] Mario Delgado,et al. Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease , 2001, Nature Medicine.
[66] Thomas A. Luger,et al. Proteinase-Activated Receptor-2 Mediates Itch: A Novel Pathway for Pruritus in Human Skin , 2003, The Journal of Neuroscience.
[67] M. Schultzberg,et al. Somatostatin- and factor XIIIa-immunoreactive cells in psoriasis during clobetasol propionate and calciprotriol treatment. , 1999, Acta dermato-venereologica.
[68] F. Legat,et al. The cutaneous neurosensory system in skin disease. , 2002, Advances in dermatology.
[69] T. Williams,et al. The partial inhibition of inflammatory responses induced by capsaicin using the fab fragment of a selective calcitonin gene-related peptide antiserum in rabbit skin , 1992, Neuroscience.
[70] J. Wagner,et al. Catecholamines Inhibit the Antigen-Presenting Capability of Epidermal Langerhans Cells1 , 2002, The Journal of Immunology.
[71] K. Schallreuter,et al. Epidermal adrenergic signal transduction as part of the neuronal network in the human epidermis. , 1997, The journal of investigative dermatology. Symposium proceedings.
[72] K. Sato,et al. Effect of VIP on sweat secretion and cAMP accumulation in isolated simian eccrine glands. , 1987, The American journal of physiology.
[73] S. Brain. New feelings about the role of sensory nerves in inflammation , 2000, Nature Medicine.
[74] L. Misery,et al. Binding and in vitro modulation of human epidermal Langerhans cell functions by substance P , 1997, Archives of Dermatological Research.
[75] J. Olerud,et al. Dermatitis P-Induced Inflammation in Allergic Contact Neutral Endopeptidase Terminates Substance , 2000 .
[76] I. Black,et al. Expression of catecholaminergic characteristics by primary sensory neurons in the normal adult rat in vivo. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[77] M. Simon,et al. alpha-Melanocyte-stimulating hormone induces hapten-specific tolerance in mice. , 1996, Journal of immunology.
[78] H. Vaudry,et al. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. , 2000, Pharmacological reviews.
[79] B. Gilchrest,et al. Innervation of melanocytes in human skin , 1996, The Journal of experimental medicine.
[80] L. Kemény,et al. Effects of the Neuropeptides Substance P, Calcitonin Gene-Related Peptide and α-Melanocyte-Stimulating Hormone on the IL-8/IL-8 Receptor System in a Cultured Human Keratinocyte Cell Line and Dermal Fibroblasts , 1999, Inflammation.
[81] J. Haycock,et al. α‐MSH Immunomodulation Acts via Rel/NF‐κB in Cutaneous and Ocular Melanocytes and in Melanoma Cells , 1999 .
[82] S. L. Dun,et al. Pituitary adenylate cyclase activating polypeptide-immunoreactivity in human spinal cord and dorsal root ganglia , 1996, Brain Research.
[83] B. Zelickson,et al. Agarose gel keratinocyte outgrowth system as a model of skin re-epithelization: requirement of endogenous acetylcholine for outgrowth initiation. , 1993, The Journal of investigative dermatology.
[84] S. Eichmüller,et al. Neural mechanisms of hair growth control. , 1997, The journal of investigative dermatology. Symposium proceedings.
[85] T. Luger,et al. Alpha-melanocyte stimulating hormone prevents lipopolysaccharide-induced vasculitis by down-regulating endothelial cell adhesion molecule expression. , 2003, Endocrinology.
[86] T. Luger,et al. Expression of proopiomelanocortin peptides in human dermal microvascular endothelial cells: evidence for a regulation by ultraviolet light and interleukin-1. , 2000, The Journal of investigative dermatology.
[87] D. Metcalfe,et al. Receptor-mediated modulation of murine mast cell function by alpha-melanocyte stimulating hormone. , 1999, Journal of immunology.
[88] Cioca Daniel Petru,et al. Apoptosis of peripheral blood lymphocytes is induced by catecholamines. , 2000, Japanese heart journal.
[89] J. Olerud,et al. Interactions of the skin and nervous system. , 1997, Journal of Investigative Dermatology Symposium Proceedings.
[90] J. Wallace,et al. Agonists of proteinase‐activated receptor 1 induce plasma extravasation by a neurogenic mechanism , 2001, British journal of pharmacology.
[91] C. Wiedermann,et al. Stimulation of the chemotactic migration of human fibroblasts by substance P. , 1993, European journal of pharmacology.
[92] M. Kress,et al. Topical acetyl salicylate and dipyrone attenuate neurogenic protein extravasation in rat skin in vivo , 2000, Neuroscience Letters.
[93] G. Calo’,et al. B1 and B2 kinin receptors in various species. , 1997, Immunopharmacology.
[94] J. Cockcroft,et al. Pituitary Adenylate Cyclase Activating Polypeptide is a Potent Vasodilator in Humans , 1992, Journal of cardiovascular pharmacology.
[95] G. Chrousos,et al. Corticotropin-Releasing Hormone Induces Skin Mast Cell Degranulation and Increased Vascular Permeability, A Possible Explanation for Its Proinflammatory Effects. , 1998, Endocrinology.
[96] T. Williams,et al. Interactions between the tachykinins and calcitonin gene‐related peptide lead to the modulation of oedema formation and blood flow in rat skin , 1989, British journal of pharmacology.
[97] T. X. Lee,et al. Activation of keratinocyte nicotinic cholinergic receptors stimulates calcium influx and enhances cell differentiation. , 1996, The Journal of investigative dermatology.
[98] C. Shaw,et al. The regional distribution of neuropeptides in human skin as assessed by radioimmunoassay and high‐performance liquid chromatography , 1994, Clinical and experimental dermatology.
[99] A. Johnson,et al. Cytokines increase neutral endopeptidase activity in lung fibroblasts. , 1993, American journal of respiratory cell and molecular biology.
[100] Ruoyan Chen,et al. Macrophages, But Not T and B Lymphocytes, Are Critical for Subepidermal Blister Formation in Experimental Bullous Pemphigoid: Macrophage-Mediated Neutrophil Infiltration Depends on Mast Cell Activation1 , 2002, The Journal of Immunology.
[101] R. Granstein,et al. Neuropeptides and neuroendocrine hormones in ultraviolet radiation-induced immunosuppression. , 2002, Methods.
[102] R. Buchli,et al. Identification and Mapping of Keratinocyte Muscarinic Acetylcholine Receptor Subtypes in Human Epidermis1 , 1998 .
[103] J. Warren,et al. Opposing roles of cyclic AMP in the vascular control of edema formation , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[104] F. Fantini,et al. Nerve growth factor is increased in psoriatic skin. , 1995, The Journal of investigative dermatology.
[105] A. Chakraborty,et al. The effect of thioredoxin on the expression of proopiomelanocortin-derived peptides, the melanocortin 1 receptor and cell survival of normal human keratinocytes. , 2001, The journal of investigative dermatology. Symposium proceedings.
[106] U. Wahn,et al. Down-regulation of vasoactive intestinal polypeptide receptor expression in atopic dermatitis. , 2003, The Journal of allergy and clinical immunology.
[107] J. Haycock,et al. Inhibition of Tumor Necrosis Factor-α Stimulated NFκB/p65 in Human Keratinocytes by α-Melanocyte Stimulating Hormone and Adrenocorticotropic Hormone Peptides , 2002 .
[108] S. Bischoff,et al. Opposing effects of tumor necrosis factor‐α and nerve growth factor upon leukotriene C4 production by human eosinophils triggered with N‐formyl‐methionyl‐leucyl‐phenylalanine , 1992, European journal of immunology.
[109] J. Szolcsányi. Capsaicin-sensitive sensory nerve terminals with local and systemic efferent functions: facts and scopes of an unorthodox neuroregulatory mechanism. , 1996, Progress in brain research.
[110] M. Mukoyama,et al. Rat receptor-activity-modifying proteins (RAMPs) for adrenomedullin/CGRP receptor: cloning and upregulation in obstructive nephropathy. , 2000, Biochemical and biophysical research communications.
[111] C. Wiedermann,et al. Induction of endothelial cell differentiation into capillary-like structures by substance P. , 1996, European journal of pharmacology.
[112] J. Warren,et al. Pituitary adenylate cyclase activating polypeptide is a potent vasodilator and oedema potentiator in rabbit skin in vivo , 1992, British journal of pharmacology.
[113] E. Pintér,et al. Neurokinin-1 Receptor Agonists Are Involved in Mediating Neutrophil Accumulation in the Inflamed, But Not Normal, Cutaneous Microvasculature: An In Vivo Study Using Neurokinin-1 Receptor Knockout Mice1 , 2000, The Journal of Immunology.
[114] D. Michikami,et al. Interrelations of vasoconstrictor sympathetic outflow to skin and core temperature during unilateral sole heating in humans , 2001, Autonomic Neuroscience.
[115] M. Schaller,et al. Endothelium-Dependent Vasodilation in the Skin Microcirculation of Patients with Septic Shock , 2003, Shock.
[116] J. Pisegna. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and Its Receptor , 2003 .
[117] J. Kessler,et al. Cytokine regulation of substance P expression in sympathetic neurons. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[118] R. Plevin,et al. Proteinase-activated Receptor-2-mediated Activation of Stress-activated Protein Kinases and Inhibitory κB Kinases in NCTC 2544 Keratinocytes* , 2001, The Journal of Biological Chemistry.
[119] D. Pozo,et al. Vasoactive Intestinal Peptide (VIP) and Pituitary Adenylate Cyclase-Activation Polypeptide (PACAP) Protect Mice from Lethal Endotoxemia Through the Inhibition of TNF-α and IL-6 , 1999, The Journal of Immunology.
[120] J. Wallace,et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism , 2000, Nature Medicine.
[121] K. Nishioka,et al. Substance P augments fibrogenic cytokine-induced fibroblast proliferation: possible involvement of neuropeptide in tissue fibrosis. , 1997, Journal of dermatological science.
[122] T. Luger,et al. Molecular Basis of the α‐MSH/IL‐1 Antagonism , 1999 .
[123] C. Stein,et al. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: Evidence for a regulatory function of nerve growth factor in vivo , 1992, Neuroscience.
[124] M. Spaargaren,et al. Regulation of Cytokine Signaling by B Cell Antigen Receptor and Cd40-Controlled Expression of Heparan Sulfate Proteoglycans , 2000, The Journal of experimental medicine.
[125] J. M. Lipton,et al. The Neuropeptide α‐MSH in Host Defense , 2000 .
[126] T. Williams,et al. VASOACTIVE INTESTINAL POLYPEPTIDE IS MORE POTENT THAN PROSTAGLANDIN E2 AS A VASODILATOR AND OEDEMA POTENTIATOR IN RABBIT SKIN , 1982, British journal of pharmacology.
[127] I. Gozes,et al. VIP and the potent analog, stearyl‐Nle17‐VIP, induce proliferation of keratinocytes , 2000, FEBS letters.
[128] J. M. Lipton,et al. NF-κB activation is inhibited in human pulmonary epithelial cells transfected with α-melanocyte-stimulating hormone vector , 2000, Peptides.
[129] A. Arimura,et al. Molecular cloning and functional expression of rat cDNAs encoding the receptor for pituitary adenylate cyclase activating polypeptide (PACAP). , 1993, Biochemical and biophysical research communications.
[130] J. Mazurkiewicz,et al. Cutaneous expression of corticotropin‐releasing hormone (CRH), urocortin, and CRH receptors , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[131] S. Galli,et al. Mast cells contribute to PACAP-induced dermal oedema in mice , 1999, Regulatory Peptides.
[132] A. Haegerstrand,et al. Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[133] S. Brain,et al. Lack of a significant effect of deletion of the tachykinin neurokinin-1 receptor on wound healing in mouse skin , 2001, Neuroscience.
[134] J. Seckl,et al. Distribution of neuropeptides in dorsal root ganglia of the rat; substance P, somatostatin and calcitonin gene-related peptide , 1993, Neuroscience Letters.
[135] Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. , 1996, Endocrine reviews.
[136] M. Steinhoff,et al. Identification of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type 1 receptor in human skin: expression of PACAP-38 is increased in patients with psoriasis , 1999, Regulatory Peptides.
[137] E. Albuquerque,et al. A nicotinic acetylcholine receptor regulating cell adhesion and motility is expressed in human keratinocytes. , 1995, The Journal of investigative dermatology.
[138] J. Brown,et al. Substance P selectively activates TNF-alpha gene expression in murine mast cells. , 1993, Journal of immunology.
[139] A. Schmidt-Choudhury,et al. Pituitary Adenylate Cyclase Activating Polypeptide Induces Degranulation of Rat Peritoneal Mast Cells via High‐Affinity PACAP Receptor‐Independent Activation of G Proteins , 1998, Annals of the New York Academy of Sciences.
[140] D. Julius,et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway , 1997, Nature.
[141] C. Wahlestedt,et al. Vascular effects of proteinase-activated receptor 2 agonist peptide. , 1997, Journal of vascular research.
[142] S. Grando,et al. Nicotine enhances expression of the alpha 3, alpha 4, alpha 5, and alpha 7 nicotinic receptors modulating calcium metabolism and regulating adhesion and motility of respiratory epithelial cells. , 1997, Research communications in molecular pathology and pharmacology.
[143] C. Stroh,et al. Agonists of proteinase-activated receptor 2 induce cytokine release and activation of nuclear transcription factor kappaB in human dermal microvascular endothelial cells. , 2002, The Journal of investigative dermatology.
[144] E. Pintér,et al. Interaction between interleukin 1β and endogenous neurokinin 1 receptor agonists in mediating plasma extravasation and neutrophil accumulation in the cutaneous microvasculature of the rat , 2002, Neuroscience Letters.
[145] F. Sundler,et al. Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: Immunocytochemical and immunochemical evidence , 1993, Neuroscience.
[146] J. Vishwanatha,et al. Effects of smokeless tobacco on chemically transformed hamster oral keratinocytes: role of angiotensin I-converting enzyme. , 1994, Carcinogenesis.
[147] T. Luger,et al. The Role of α‐MSH as a Modulator of Cutaneous Inflammation , 2000 .
[148] J. Haycock,et al. α-Melanocyte-stimulating Hormone Reduces Impact of Proinflammatory Cytokine and Peroxide-generated Oxidative Stress on Keratinocyte and Melanoma Cell Lines* , 2000, The Journal of Biological Chemistry.
[149] E. Muñoz-Elías,et al. Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Tumor Necrosis Factor α Transcriptional Activation by Regulating Nuclear Factor-kB and cAMP Response Element-binding Protein/c-Jun* , 1998, The Journal of Biological Chemistry.
[150] L. Misery,et al. Langerhans cells in the neuro-immuno-cutaneous system , 1998, Journal of Neuroimmunology.
[151] L. Kemény,et al. Alpha-melanocyte stimulating hormone induces collagenase/matrix metalloproteinase-1 in human dermal fibroblasts. , 1995, Biological chemistry Hoppe-Seyler.
[152] D. Gruenert,et al. Glucocorticoids induce neutral endopeptidase in transformed human tracheal epithelial cells. , 1991, The American journal of physiology.
[153] D. Pozo,et al. Vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide modulate endotoxin‐induced IL‐6 production by murine peritoneal macrophages , 1998, Journal of leukocyte biology.
[154] G. Wendelschafer‐Crabb,et al. Keratinocyte muscarinic acetylcholine receptors: immunolocalization and partial characterization. , 1995, The Journal of investigative dermatology.
[155] M. Steinhoff,et al. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. , 1998, American journal of physiology. Cell physiology.
[156] A. Kagey‐Sobotka,et al. Substance P activates the release of histamine from human skin mast cells through a pertussis toxin-sensitive and protein kinase C-dependent mechanism. , 1996, Clinical immunology and immunopathology.
[157] D. Borson. Roles of neutral endopeptidase in airways. , 1991, The American journal of physiology.
[158] C. Créminon,et al. Neurogenic responses mediated by vanilloid receptor‐1 (TRPV1) are blocked by the high affinity antagonist, iodo‐resiniferatoxin , 2003, British journal of pharmacology.
[159] K. Nordlind,et al. Vasoactive intestinal polypeptide in allergic contact dermatitis: an immunohistochemical and radioimmunoassay study , 1999, Archives of Dermatological Research.
[160] J. Hoxie,et al. Interactions of Mast Cell Tryptase with Thrombin Receptors and PAR-2* , 1997, The Journal of Biological Chemistry.
[161] N. Bunnett,et al. Substance P activates coincident NF-AT- and NF-kappa B-dependent adhesion molecule gene expression in microvascular endothelial cells through intracellular calcium mobilization. , 1999, Journal of immunology.
[162] T. Lee,et al. Cutaneous responses to vasoactive intestinal polypeptide in chronic idiopathic urticaria , 1992, The Lancet.
[163] Melanie G. Lee,et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor , 1998, Nature.
[164] S. Chang,et al. Vasoactive intestinal polypeptide stimulates the proliferation of HaCaT cell via TGF- α , 1999, Neuropeptides.
[165] T. Luger,et al. alpha-Melanocyte stimulating hormone acts as a selective inducer of secretory functions in human mast cells. , 2000, Biochemical and biophysical research communications.
[166] C. Estrada,et al. Neuronal Nitric Oxide Synthase Activation by Vasoactive Intestinal Peptide in Bovine Cerebral Arteries , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[167] J. Genard,et al. Renal hemodynamics and blood flow autoregulation during acute cyclooxygenase inhibition in male rats. , 1995, The American journal of physiology.
[168] T. Luger,et al. The Pilosebaceous Unit Is Part of the Skin Immune System , 1998, Dermatology.
[169] M. Macey,et al. Immunolocalization of protease‐activated receptor‐2 in skin: receptor activation stimulates interleukin‐8 secretion by keratinocytes in vitro , 1998, Immunology.
[170] J. Olerud,et al. Neuropeptide regulation of human dermal microvascular endothelial cell ICAM-1 expression and function. , 1998, American journal of physiology. Cell physiology.
[171] Williams Tj,et al. Neuropharmacology of peptides in skin. , 1988 .
[172] H. Viinamäki,et al. Association of cutaneous mast cells and sensory nerves with psychic stress in psoriasis. , 1993, Psychotherapy and psychosomatics.
[173] B. Seegal,et al. Angiotensin-converting enzyme: vascular endothelial localization. , 1976, Science.
[174] L. Petersen,et al. Pituitary adenylate cyclase activating polypeptide (PACAP) is localized in human dermal neurons and causes histamine release from skin mast cells , 1998, Inflammation Research.
[175] M. Macey,et al. Protease-activated receptors and their role in IL-6 and NF-IL-6 expression in human gingival fibroblasts. , 1998, Journal of periodontal research.
[176] R. Freeman,et al. Vascular and neural mechanisms of ACh-mediated vasodilation in the forearm cutaneous microcirculation. , 2002, Journal of applied physiology.
[177] E. Antunes,et al. The effect of a tachykinin NK1 receptor antagonist, SR140333, on oedema formation induced in rat skin by venom from the Phoneutria nigriventer spider , 1996, British journal of pharmacology.
[178] A. Haegerstrand,et al. Calcitonin gene-related peptide stimulates proliferation of human endothelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.